John Katzenellenbogen
Corporate Officer/Principal bei University of Illinois
Profil
John Katzenellenbogen is the founder of Radius Health, Inc. which was founded in 2003.
He is currently a Professor at the University of Illinois.
He holds a doctorate degree from Harvard University.
Aktive Positionen von John Katzenellenbogen
| Unternehmen | Position | Beginn |
|---|---|---|
| University of Illinois | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von John Katzenellenbogen
| Unternehmen | Position | Ende |
|---|---|---|
| RADIUS HEALTH, INC. | Gründer | - |
Ausbildung von John Katzenellenbogen
| Harvard University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
